Weighing the gold in the gold standard: challenges in HIV prevention research
Top Cited Papers
- 13 March 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 24 (5), 621-635
- https://doi.org/10.1097/qad.0b013e328337798a
Abstract
Objective(s): Few HIV prevention interventions have been evaluated in randomized controlled trials (RCTs). We examined design, implementation, and contextual considerations that may limit detection of a positive or adverse effect in HIV prevention trials. Design: A systematic review of late phase RCTs for prevention of sexual transmission of HIV that randomly allocated intervention and comparison groups; evaluated interventions to prevent sexual transmission in nonpregnant populations; and reported HIV incidence as the primary or secondary outcome. Methods: PubMed/MEDLINE, other electronic databases, and electronic conference proceedings of recent HIV/AIDS-related conferences were searched to identify published or unpublished trials meeting the inclusion criteria. Descriptive, methodological, and contextual factors were abstracted from each trial. Results: The review included 37 HIV prevention RCTs reporting on 39 unique interventions. Only six RCTs, all evaluating biomedical interventions, demonstrated definitive effects on HIV incidence. Five of the six RCTs significantly reduced HIV infection: all three male circumcision trials, one trial of sexually transmitted infection treatment and care, and one vaccine trial. One microbicide trial of nonoxynol-9 gel produced adverse results. Lack of statistical power, poor adherence, and diluted versions of the intervention in comparison groups may have been important issues for the other trials that demonstrated ‘flat’ results. Conclusion: Almost 90% of HIV prevention trials had ‘flat’ results, which may be attributable to trial design and/or implementation. The HIV prevention community must not only examine evidence from significant RCTs, but must also examine flat trials and address design and implementation issues that limit detection of an effect.Keywords
This publication has 69 references indexed in Scilit:
- Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2The New England Journal of Medicine, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandThe New England Journal of Medicine, 2009
- Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionNature Medicine, 2009
- Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trialThe Lancet, 2009
- Methodologies for evaluating HIV prevention intervention (populations and epidemiologic settings)Current Opinion in HIV and AIDS, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Effect of Herpes Simplex Suppression on Incidence of HIV among Women in TanzaniaThe New England Journal of Medicine, 2008
- Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialThe Lancet, 2007
- Uganda's HIV Prevention Success: The Role of Sexual Behavior Change and the National ResponseAIDS and Behavior, 2006